Researchers from FAU and Sancilio and Company, Inc. are collaborating to develop a treatment for Retinitis Pigmentosa, an inherited disease that causes severe progressive vision impairment and blindness.
Alana Edwards served on review panels to select applications submitted to the Department of Defense to decide how the $5 million appropriated by Congress will be spent on future tick-borne disease research.
Researchers from FAU and Harvard address the possible but unproven link between statins and diabetes and emphasize that the link to diabetes is questionable and inconsequential.
Ramon Garcia-Areas' groundbreaking research on breast cancer has earned him a prestigious post-doctoral fellowship at Institut Curie Pasteur in Paris, one of the world's leading research institutes.
A new study at FAU is the first to demonstrate that the Parkin gene is turned on when cells are exposed to environmental insults that cause free radical formation and cataract formation.
Janet Robishaw, Ph.D., a leader in functional and translational genomics, has been appointed as chair of the Department of Biomedical Sciences in FAU's Charles E. Schmidt College of Medicine.
FAU has entered into a licensing agreement with Neuro Pharmalogics, Inc., a biopharmaceutical company focused on developing and commercializing innovative therapies for patients with rare neurological diseases.
FAU Harbor Branch study shows the relationship between changing sea ice and beluga whale migration and habitat patterns of several populations over two decades of dramatic sea ice changes in the Pacific Arctic.
FAU researchers and collaborators conducted a first-of-its-kind longitudinal study on twins to identify the degree to which siblings contribute to the increase in delinquent behavior and alcohol misuse.
The FAU community came together to start a Help for Haiti relief effort in the aftermath of Hurricane Matthew.